NCT00732693View on ClinicalTrials.gov

Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Premature Ovarian Failure
Interventions
DRUG

Ethinylestradiol / Norethisterone

"Oral ethinylestradiol 30mcg and norethisterone 1.5mg daily for weeks 1-3, followed by 7 pill free days"

DRUG

Estradiol / Progesterone

Transdermal estradiol 100mcg daily for week 1, then 150mcg daily for weeks 2-4; and vaginal progesterone pessaries 200mg twice daily for weeks 3-4

Trial Locations (2)

EH16 4SA

Royal Infirmary of Edinburgh, Edinburgh

EH9 1LF

Royal Hospital for Sick Children, Edinburgh

All Listed Sponsors
lead

University of Edinburgh

OTHER

NCT00732693 - Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure | Biotech Hunter | Biotech Hunter